Bayesian Capital Management, LP Sangamo Therapeutics, Inc Transaction History

Bayesian Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $27,027 - $51,170	8,240 Added 36.2%	31,000 $128,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $119,034 - $177,983	22,760 New	22,760 $132,000
Q3 2020 Nov 12, 2020	SELL	$9.38 - $12.48 $503,706 - $670,176	-53,700 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $349,623 - $666,029	-56,300 Reduced 51.18%	53,700 $481,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $555,500 - $973,500	110,000 New	110,000 $701,000
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $169,845 - $247,935	-13,015 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $241,762 - $344,381	-17,393 Reduced 57.2%	13,015 $185,000
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $507,813 - $801,250	30,408 New	30,408 $578,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.